XLOCK BIOSCIENCES, LLC

Harnessing the potential of chemokine biology

MUSKEGO, United States · Founded 2020 · $360K raised

Headquarters
MUSKEGO, Wisconsin
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$360K
Last Round
$260K GrantJan 2022
Rounds
2

About

XLock Biosciences is a clinical-stage biotech company harnessing chemokine biology to develop next-generation precision therapeutics in immunology and oncology. Using deep expertise in protein engineering and immune system modulation, XLock's lead compound CCL20 Locked Dimer (CCL20LD) selectively targets disease-driving Th17-mediated pathways. The company has demonstrated preclinical efficacy in psoriasis, psoriatic arthritis, and chronic graft-versus-host disease.

Summary

XLOCK BIOSCIENCES, LLC is a Biotech company based in MUSKEGO, United States, founded in 2020. It has raised $360K in total across 2 rounds, most recently a $260K Grant round in Jan 2022. Investors include National Institutes of Health.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2022
$260K

Sign up to see all 2 rounds

Grant through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

XLOCK BIOSCIENCES, LLC on Indexed.vc
<a href="https://indexed.vc/companies/xlock-biosciences-llc"><img src="https://indexed.vc/api/badge/company/xlock-biosciences-llc" alt="XLOCK BIOSCIENCES, LLC on Indexed.vc" width="260" height="76" /></a>